Study tests recast therapy for bilingual children with developmental language disorder

Amanda Owen Van Horne sits on the floor while a child mixes up cake batter in a play kitchen.

Detailed data on Alnylam’s heart drug show substantial benefit, while competition likely awaits

LONDON — An experimental drug from Alnylam Pharmaceuticals substantially cut the risk of death and serious cardiovascular complications among patients with an increasingly diagnosed heart

August 30, 2024

Vertex pain drug results met with measured optimism — and questions — by observers and experts

Late-stage trial results for a pain medication developed by Vertex Pharmaceuticals reinforced experts’ sense that the drug was both safe and offered modest pain relief.

January 30, 2024

The FDA awarded a record number of review designations to mRNA vaccines in 2023

The success of the Covid-19 messenger ribonucleic acid (mRNA) vaccines highlighted the major advantages of utilising mRNA technology in vaccine development. Consequently, the US Food

June 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.